Using genetically engineered mouse models and tetracycline-regulated AKT isoform shRNA, it was found that in prostate cancer, AKT1 promotes tumor growth, and AKT2 promotes metastasis [257, 265]. This evidence concerns the gene AKT1 and neoplasm.